Sciele Pharma, Inc., a Shionogi Group Company, Announces Name Change to Shionogi Pharma, Inc.

Published: Jan 12, 2010

ATLANTA--(BUSINESS WIRE)--Sciele Pharma, Inc.: Shionogi & Co., Ltd. (Head Office: Osaka; President: Isao Teshirogi; hereafter “Shionogi”) today announced that its U.S.-based group company, Sciele Pharma, Inc. (hereafter “Sciele”), and two group companies have changed their company names as detailed below.

Back to news